Non-Lethal Endotoxin Injection: A Rat Model of Hypercoagulability

Marjory B. Brooks,James R. Turk,Abraham Guerrero,Padma K. Narayanan,John P. Nolan,Elizabeth G. Besteman,Dennis W. Wilson,Roberta A. Thomas,Cindy E. Fishman,Karol L. Thompson,Heidrun Ellinger-Ziegelbauer,Jennifer B. Pierson,April Paulman,Alan Y. Chiang,Albert E. Schultze
DOI: https://doi.org/10.1371/journal.pone.0169976
IF: 3.7
2017-01-12
PLoS ONE
Abstract:Systemic inflammation co-activates coagulation, which unchecked culminates in a lethal syndrome of multi-organ microvascular thrombosis known as disseminated intravascular coagulation (DIC). We studied an endotoxin-induced inflammatory state in rats to identify biomarkers of hemostatic imbalance favoring hypercoagulability. Intraperitoneal injection of LPS at 15 mg/kg body weight resulted in peripheral leukopenia and widespread neutrophilic sequestration characteristic of an acute systemic inflammatory response. Early indicators of hemostatic pathway activation developed within 4 hours, including increased circulating concentrations of procoagulant extracellular vesicles (EVs), EVs expressing endothelial cell and platelet membrane markers, and high concentration of soluble intercellular adhesion molecule-1 (sICAM-1), plasminogen activator inhibitor-1 (PAI-1), and D-dimers. Inflammation persisted throughout the 48-hour observation period; however, increases were found in a subset of serum microRNA (miRNA) that coincided with gradual resolution of hemostatic protein abnormalities and reduction in EV counts. Dose-adjusted LPS treatment in rats provides a time-course model to develop biomarker profiles reflecting procoagulant imbalance and rebalance under inflammatory conditions.
multidisciplinary sciences
What problem does this paper attempt to address?